[
  {
    "ts": null,
    "headline": "Dow's J&J Surges; Why Its Report Is Also Bullish For Stryker, Medtronic, Boston Scientific",
    "summary": "Johnson & Johnson stock jumped Wednesday after the Dow health behemoth raised its guidance in the wake of a bullish second-quarter report.",
    "url": "https://finnhub.io/api/news?id=bde551605064334a90731aafc81857fcde95002fd3ab29bca1d8d033fb9becd0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752696414,
      "headline": "Dow's J&J Surges; Why Its Report Is Also Bullish For Stryker, Medtronic, Boston Scientific",
      "id": 135993601,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Johnson & Johnson stock jumped Wednesday after the Dow health behemoth raised its guidance in the wake of a bullish second-quarter report.",
      "url": "https://finnhub.io/api/news?id=bde551605064334a90731aafc81857fcde95002fd3ab29bca1d8d033fb9becd0"
    }
  },
  {
    "ts": null,
    "headline": "ANGO Stock Down Despite Q4 Earnings Beat, Gross Margin Declines",
    "summary": "AngioDynamics beats fourth-quarter fiscal 2025 estimates with strong Med Tech growth amid margin declines and a wider fiscal 2026 loss outlook.",
    "url": "https://finnhub.io/api/news?id=bb9f004af89fcbe3f28aaef14c41a6d7495c564644903b82c6d73bfbb183f805",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752683700,
      "headline": "ANGO Stock Down Despite Q4 Earnings Beat, Gross Margin Declines",
      "id": 135993603,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "AngioDynamics beats fourth-quarter fiscal 2025 estimates with strong Med Tech growth amid margin declines and a wider fiscal 2026 loss outlook.",
      "url": "https://finnhub.io/api/news?id=bb9f004af89fcbe3f28aaef14c41a6d7495c564644903b82c6d73bfbb183f805"
    }
  },
  {
    "ts": null,
    "headline": "Reasons to Add DENTSPLY SIRONA Stock to Your Portfolio Now",
    "summary": "XRAY gains traction with digital implants, R&D strength, and Q1 margin growth despite softness in Europe.",
    "url": "https://finnhub.io/api/news?id=3ebe88398fedc643c91fed2ea113fe451a174cc6c02e1d55078aa90275a50b43",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752683160,
      "headline": "Reasons to Add DENTSPLY SIRONA Stock to Your Portfolio Now",
      "id": 135993604,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "XRAY gains traction with digital implants, R&D strength, and Q1 margin growth despite softness in Europe.",
      "url": "https://finnhub.io/api/news?id=3ebe88398fedc643c91fed2ea113fe451a174cc6c02e1d55078aa90275a50b43"
    }
  },
  {
    "ts": null,
    "headline": "PAHC or BSX: Which Is the Better Value Stock Right Now?",
    "summary": "PAHC vs. BSX: Which Stock Is the Better Value Option?",
    "url": "https://finnhub.io/api/news?id=4ada7ce522b6589002cb7a56d7a4cab7cc2dea03d8dde0ddd276a08d5dfe2b06",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752680404,
      "headline": "PAHC or BSX: Which Is the Better Value Stock Right Now?",
      "id": 135993606,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "PAHC vs. BSX: Which Stock Is the Better Value Option?",
      "url": "https://finnhub.io/api/news?id=4ada7ce522b6589002cb7a56d7a4cab7cc2dea03d8dde0ddd276a08d5dfe2b06"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific (BSX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release",
    "summary": "Boston Scientific (BSX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "url": "https://finnhub.io/api/news?id=7773075c9dd00a45f045f4772dd0c5db88ceda21d2c1cd225fa652ffee35d441",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752674406,
      "headline": "Boston Scientific (BSX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release",
      "id": 135993607,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific (BSX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
      "url": "https://finnhub.io/api/news?id=7773075c9dd00a45f045f4772dd0c5db88ceda21d2c1cd225fa652ffee35d441"
    }
  },
  {
    "ts": null,
    "headline": "GMED Unveils Next-Gen Oscillating System DuraPro: Stock to Gain?",
    "summary": "Globus Medical debuts DuraPro with Excelsius integration, boosting its Power Portfolio.",
    "url": "https://finnhub.io/api/news?id=8354667fc340f432e5f330354c19b1c16fae68122028e44503647669cd650b62",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752671040,
      "headline": "GMED Unveils Next-Gen Oscillating System DuraPro: Stock to Gain?",
      "id": 135993609,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Globus Medical debuts DuraPro with Excelsius integration, boosting its Power Portfolio.",
      "url": "https://finnhub.io/api/news?id=8354667fc340f432e5f330354c19b1c16fae68122028e44503647669cd650b62"
    }
  },
  {
    "ts": null,
    "headline": "Is Boston Scientific Corporation (NYSE:BSX) Worth US$103 Based On Its Intrinsic Value?",
    "summary": "Key Insights Boston Scientific's estimated fair value is US$78.65 based on 2 Stage Free Cash Flow to Equity Boston...",
    "url": "https://finnhub.io/api/news?id=44f91aaf539be98cd5486ae01b34f00437a8d3f069fa190306e6e413c94525c8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752663625,
      "headline": "Is Boston Scientific Corporation (NYSE:BSX) Worth US$103 Based On Its Intrinsic Value?",
      "id": 135965476,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Key Insights Boston Scientific's estimated fair value is US$78.65 based on 2 Stage Free Cash Flow to Equity Boston...",
      "url": "https://finnhub.io/api/news?id=44f91aaf539be98cd5486ae01b34f00437a8d3f069fa190306e6e413c94525c8"
    }
  }
]